Dr. Gaurav Datta, MD

Dr. Datta practices at Arbor Rehabilitation & Nursing Center in Lodi, California.

Dr. Datta's NPI, 1225184765, was assigned on January 26, 2007. Dr. Datta graduated from Banaras Hindu University IOM in 1996. Dr. Datta holds California license C153705.

Dr. Datta's primary practice is Arbor Rehabilitation & Nursing Center, at 900 North Church Street, Lodi, CA 95240 in San Joaquin County. The practice phone is (209) 333-1222.

Dr. Datta's primary practice is Arbor Rehabilitation & Nursing Center in Lodi, California. The medical group on file is Inpatient Specialist of California PC. Dmand AI also links Dr. Datta to 6 more medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Datta practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Datta's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Datta is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Datta's licenses on file in 2 states: California and Wisconsin.

Dmand AI lists acid reflux, aneurysm, atrial fibrillation and flutter, cerebrovascular disease, chronic anemia, chronic diabetes, chronic hypertension and chronic inflammatory bowel disease (IBD) among the conditions Dr. Datta treats.

CMS data shows 752 Medicare services from Dr. Datta across 3 procedure codes in 2024, for 130 Medicare patients. Medicare paid $71,039 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 130 Medicare patients who saw Dr. Datta in 2024. The largest group is 75 to 84, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Datta's median patient age at 74, with 50% women.

In 2024, Dr. Datta wrote 1,715 Medicare Part D claims for 121 patients. 82% of them were for generic drugs. CMS names the drug for 1,162 of them, across 42 drugs with 11 or more claims each, at $56,636 in total drug cost. In 2023, CMS named 230 claims across 13 drugs.

Dr. Datta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Datta as offering telehealth.

Dmand AI links 26 papers to Dr. Datta, published from 2013 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Plasmodium falciparum, Mitochondria and HIV-1. Dr. Datta has published most often in Cancer Rep (Hoboken). Dr. Datta's most frequent co-authors are Xuesong Chen, MD, Pankaj Malhotra, MD and Harkirat Singh.

CMS Open Payments shows 4 general payments to Dr. Datta from 3 drug and device companies in 2018. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $40.

Dr. Datta graduated from Banaras Hindu University IOM in 1996.

Dr. Datta is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.